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Background: Adaptations to a new environment, such as a polluted one, often involve large modifications of the
existing phenotypes. Changes in gene expression and regulation during critical developmental stages may explain
these phenotypic changes. Embryos from a population of the teleost fish, Fundulus heteroclitus, inhabiting a clean
estuary do not survive when exposed to sediment extract from a site highly contaminated with polycyclic aromatic
hydrocarbons (PAHs) while embryos derived from a population inhabiting a PAH polluted estuary are remarkably
resistant to the polluted sediment extract. We exposed embryos from these two populations to surrogate model
PAHs and analyzed changes in gene expression, morphology, and cardiac physiology in order to better understand
sensitivity and adaptive resistance mechanisms mediating PAH exposure during development.
Results: The synergistic effects of two model PAHs, an aryl hydrocarbon receptor (AHR) agonist (β-naphthoflavone)
and a cytochrome P4501A (CYP1A) inhibitor (α-naphthoflavone), caused significant developmental delays, impaired
cardiac function, severe morphological alterations and failure to hatch, leading to the deaths of reference embryos;
resistant embryos were mostly unaffected. Unexpectedly, patterns of gene expression among normal and
moderately deformed embryos were similar, and only severely deformed embryos showed a contrasting pattern of
gene expression. Given the drastic morphological differences between reference and resistant embryos, a
surprisingly low percentage of genes, 2.24% of 6,754 analyzed, show statistically significant differences in transcript
levels during late organogenesis between the two embryo populations.
Conclusions: Our study demonstrates important contrasts in responses between reference and resistant natural
embryo populations to synergistic effects of surrogate model PAHs that may be important in adaptive mechanisms
mediating PAH effects during fish embryo development. These results suggest that statistically significant changes
in gene expression of relatively few genes contribute to the phenotypic changes and large morphological
differences exhibited by reference and resistant populations upon exposure to PAH pollutants. By correlating
cardiac physiology and morphology with changes in gene expression patterns of reference and resistant embryos, we
provide additional evidence for acquired resistance among embryos whose parents live at heavily contaminated sites.
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We studied genomic responses to the effects of chemicals
routinely found in complex mixtures of pollutants present
in the urban estuaries during late organogenesis of Fundu-
lus heteroclitus embryos. Natural Fundulus populations
are one of the few studied fish species in North America
that have established resistant populations in highly con-
taminated urban estuaries [1]. Changes in gene expression,
coupled with biochemical, physiological, and behavioral
alterations play a critical role in adaptation to environ-
mental stress. Our study explores the ways natural popu-
lations may have adapted to local polluted environments
by correlating their genomic responses to changes in
morphology and physiology during development.
Fundulus heteroclitus, a small, abundant, salt marsh
fish that inhabits the eastern North American coast, has
become a leading model in environmental biology. Nat-
ural Fundulus populations can tolerate a variety of envir-
onmental conditions and display an array of adaptations
to both natural and anthropogenic variables in their eco-
systems. F. heteroclitus is an ecologically important and
genetically diverse model to elucidate pollution effects and
genotype–environment interactions within and among
natural populations.
F. heteroclitus is one of the few studied species in
North America living in the highly polluted urban estu-
aries that has shown resistance to pollutants among both
adults and embryos [2-5]. Multiple Fundulus popula-
tions inhabit and have adapted to heavily contaminated
urban estuaries [4,6,7] which contain persistent and
bioaccumulative chemicals that are toxic to early fish de-
velopment [2,4]. Acute and chronic exposure of Fundu-
lus embryos to chemicals present in the polluted sites
can lead to functional deficit, growth retardation, mal-
formation, and even death [3,4,6].
Resistance to the lethal effects of pollution has been
reported in F. heteroclitus embryos from the Elizabeth
River, VA, a Superfund site contaminated with creosote,
a mixture of polycyclic aromatic hydrocarbons (PAHs)
[7,8]. PAHs are petroleum products created by the com-
bustion of organic materials that originate from both nat-
ural and anthropogenic sources. They have been found at
600 of 1,430 National Priority List sites, and as a group
they are ranked number eight on the 2007 Comprehensive
Environmental Response, Compensation, and Liability Act
(CERCLA) priority list of hazardous substances [9,10].
These chemicals pose a significant risk to human and ani-
mal health due to their carcinogenic properties; research
in aquatic organisms has described their equally damaging
role as teratogens [11,12]. The PAH concentrations in the
sediments collected at the Elizabeth River site are some of
the highest in the world [8], averaging 200–400 ug/g.
These PAHs include carcinogens, such as benzo(a)pyrene
(BaP), chrysene, and dibenzo(a,h) anthracene [13,14].Cardiovascular malformations, resulting in significantly
higher mortality rates, are well documented in fishes ex-
posed to PAH mixtures [12,15-18]. Some of these effects
are thought to be mediated by the aryl hydrocarbon recep-
tor (AHR) [15,19-22]. Studies of cardiovascular effects
using model PAHs show synergistic interaction between
PAH-type AHR agonists and CYP1A-inhibitors. Typically,
the AHR pathway is induced by PAHs and activates ex-
pression of CYP1A [23]. In F. heteroclitus, embryos ex-
posed to the PAH-type AHR agonist β-naphthoflavone
(BNF) and the CYP1A inhibitor α-naphthoflavone (ANF)
had decreased levels of CYP1A activity and a synergistic
increase in the occurrence of cardiac deformities as mea-
sured by heart elongation and pericardial edema [17].
BNF and ANF are synthetic flavonoids commonly used as
surrogate model PAHs: BNF acts as an AHR agonist and
ANF acts as a reversible competitive CYP1A inhibitor that
can bind to either the active site or the ferric heme
[24-26]. Agonists and inhibitors often co-occur in typical
PAH mixtures, and although the current risk assessments
of PAHs assumes an additive model of PAH toxicity, this
synergy may be an important outcome for risks posed by
PAH-exposure.
Fundulus gene-environment interaction studies include
both natural and anthropogenic environmental effects on
anatomy, physiology, development, molecular biology, and
recently a genome [27-30]. Consequently, natural Fundulus
populations have become a preferred model to study
teleost evolutionary adaptations to a range of selective
pressures. The effects of pollution on Fundulus’ genetics
have been studied in some populations [1,31-36]; however,
little is known about functionally important variation in
embryo gene expression underlying resistance mechanisms.
To explore the response differences between reference
and resistant populations to pollution at the genomic
and molecular level, we exposed embryos of parents
from King’s Creek, VA (reference) and Elizabeth River, VA
(resistant) to a defined surrogate mixture of PAH pollutants,
which are routinely found in the contaminated sediment
extracts. By correlating multiple phenotypes to changes in
gene expression patterns, we provide additional evidence
for acquired resistance among embryos whose parents live
at heavily contaminated sites.
We chose to study late organogenesis of Fundulus de-
velopment due to its high metabolic activity, observable
phenotypes, and likely cumulative effect of chemical ex-
posure on organ anatomy and physiology. Hence, we
compare survival rates, time-to-stage, morphology, car-
diac physiology, and gene expression profiles of individ-
ual Fundulus embryos from PAH-reference and resistant
natural populations exposed to a mixture of two model
PAHs at environmentally relevant concentrations [14].
Our study demonstrates important contrasts in responses
between reference and resistant embryos to synergistic
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notypes and significant changes in gene expression reveal
evidence for acquired resistance among embryos from
heavily contaminated sites. However, while the phenotypic
alterations are comparable to embryo responses to pol-
luted sediment extracts (unpublished data), a surprisingly
few number of significant genes reflect differences in se-
verity of synergistic effects between the two embryo
populations.
Results
Embryo survival, hatching success, and developmental
delays
During Fundulus late organogenesis (stage 31), survival
rates were not significantly different between popula-
tions for all treatment groups (2-way ANOVA, p = 0.97;
Figure 1A. The lowest survival was noted among reference
embryos treated with low ANF (50 ug/L, 71.1% ±10.7),
while the highest survival rate was among resistantA B
C D
Figure 1 Survival, developmental delays, and heart rates of reference
Fundulus embryos. A) Embryo survival (2-way ANOVA, p = 0.97) among fiv
at developmental stage 31 (late organogenesis). Sensitive and resistant em
B) Hatching success and survival to stage 40 (2-way ANOVA, p < 0.01) amo
combined treatments have significant effect among sensitive embryos, as t
unaffected. C) Development among control and five treatment groups of refe
most of the embryos reached stage 31 within the expected time period
embryos exposed to both low and high ANF + BNF treatments (2-way A
(on average 3 developmental stages, ~ 40 h) relative to resistant embryos in b
while embryo development in discrete treatments did not significantly differ.
during stage 31: significant bradycardia (2-way ANOVA, p < 0.01) were noted
(p < 0.05; t = 8.03) BNF/ANF dose exposures relative to resistant embryos.
differences (Student’s t-test, p < 0.05) between Elizabeth River (resistant)embryos (90% ± 5.0) treated with BNF (1 ug/L) + high
ANF (100 ug/L). All of the embryos that hatched sur-
vived to the final embryonic stage characterized by
complete yolk consumption and free-swimming larvae.
At stage 40, all of the reference embryos failed to
hatch and did not survive either the lower or higher
ANF/BNF co-exposure (Figure 1B). A 2-way ANOVA
(p < 0.05) indicated significant differences in hatching
success among embryo treatment groups. Bonferroni’s
post-test revealed significant differences between refer-
ence and resistant embryos for both BNF + low ANF
(p < 0.001, t = 6.74), and BNF + high ANF (p < 0.001,
t = 6.12) treatment groups.
Although most of the embryos reached stage 31 within
the expected time period, significant developmental de-
lays were noted among reference embryos exposed to
both low and high ANF + BNF treatments (2-way ANOVA,
P <0.01; Figure 1C). Bonferroni post-test analysis of devel-
opmental stage at 144–150 hours post fertilization revealed(Kings’ Creek – blue) and resistant (Elizabeth River – red)
e treatment groups within reference and resistant embryo populations
bryo’s survival is not affected by any treatment at the stage 31.
ng reference and resistant embryos. The cumulative effects in both
hey fail to hatch, while the resistant embryo survival is largely
rence and resistant embryos at 144–150 hours post-fertilization: although
, significant developmental delays were noted among reference
NOVA, P <0.01). Reference embryos were significantly delayed
oth combined treatments (Bonferroni post-test analysis, p < 0.01),
D) Embryo heart rates: reference and resistant embryos’ heart rates
among reference embryos at both lower (p < 0.04; t = 4.12) and higher
Asterisks (*) represent statistically significant within-treatment
and King’s Creek (reference) embryos.
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tween reference and resistant embryos in both combined
treatments (p < 0.01), while embryo development in
discrete treatments did not significantly differ. Refer-
ence embryos were on average 3 stages behind (approxi-
mately 40 hours) when compared to resistant embryos
from the same combined treatment group (2-tailed t-test,
p < 0.01).
Heart rate
Heart rate results at stage 31 mirrored developmental
delay data: significantly slower heart rates (bradycardia;
2 way-ANOVA, p < 0.01; Figure 1D) were noted among
sensitive embryos in combined treatment groups. Bon-
ferroni post-test revealed statistically significant differ-
ences in reference embryos exposed to BNF + low ANF
(100.5 ± 10.1 bpm; p < 0.01; t = 4.12) and BNF + high
ANF (66.3 ± 36.8 bpm; p < 0.01; t =8.03) when compared
to all other treatment groups in both reference and re-
sistant embryo populations.
Embryo morphology
Severe and extreme morphological abnormalities were
noted among all reference embryos in combined treat-
ment groups (Figure 2B). These deformities included
pericardial edema, hemorrhaging, cranio-facial malfor-
mations, tail shortening and bleeding, and general loss
of pigment (Figure 2A). The most severely affected refer-
ence embryos in BNF + high ANF treatments were char-
acterized by overall smaller size, loss of cranial ridges,
cranium size reduction with diminished eye distance, ag-
gregation and reduction of body pigmentation and hem-
orrhaging throughout the entire caudal region; these
morphologies were only observed among the reference
embryos in higher co-exposure treatment group. Their
hearts (score > 4 on a scale of 1–5 where 1 indicates no
deformity and 5 indicates extreme deformity) failed to
differentiate, resulting in a “tube-heart” structure, which
appears as a barely-visible long tube through which
transparent fluid slowly trickles (instead of 2 fully-
formed round chambers with red blood forcefully pump-
ing from the atrium into a ventricle, as seen in the
control embryos). The average score for the BNF + low
ANF treatment group was 3.7 and was 4.6 for the BNF +
high ANF treatment group. Any embryo with a score > 3
failed to hatch. Statistical differences (Bonferroni post-test,
p < 0.05) were noted between reference and resistant em-
bryos in 4/6 treatments, with reference embryos being sig-
nificantly more deformed at low ANF (p < 0.05; t = 2.91),
high ANF (p < 0.01; t = 5.827), BNF + low ANF (p < 0.01,
t = 9.71), and BNF + high ANF (p < 0.01, t = 13.11).
The relationship between heart rates and in vivo mor-
phological deformities is presented in Figure 2C-E. Com-
bined data of reference and resistant embryos show astrong correlation between heart rate and morphology
(R2 = 0.78; Figure 2E): as the deformities progress among
reference embryos throughout treatments, the bradycar-
dia becomes more pronounced, reflecting the impaired
heart function among reference embryos. A similar trend
is apparent among reference embryos only (Figure 2D)
showing the strong correlation (R2 = 0.82) between the
progression of deformities and bradycardia among refer-
ence embryos. However, this is not the case for resistant
embryos (Figure 2E), as progression of deformities does
not correlate with the decrease in heart rate (R2 = 0.044).
Moreover, the resistant embryos show a slight increase in
heart rates (tachycardia) as deformities progress. Notably,
none of the exposed resistant embryos were scored higher
than 3 (moderate deformities) while all of the reference
embryos in co-exposures with BNF and ANF were
scored between 4 (severe deformities) and 5 (extreme
deformities).
Gene expression
Of the 6,754 genes analyzed for altered expression pat-
terns, expression of 151 genes (2.24%) is significantly dif-
ferent (mixed model ANOVA, p < 0.01; Figure 3A). The
combined effect of population and treatment analysis re-
veals 73 significant genes (Figure 4A). Expression of 52
genes is significantly different due to the effect of treat-
ment alone (Figure 4B), while 26 genes are differentially
expressed due to differences between reference and re-
sistant embryo populations (Figure 4C). We found no
significant genes when a False Discovery Rate (FDR) cor-
rection is applied at p < 0.05.
Expression of 105 genes (1.6%) is significantly different
(mixed model ANOVA, p < 0.01) due to the effects of
embryo morphology among reference and resistant em-
bryos (Figure 3B). While gene expression appears similar
among embryos scored for no deformities (index 1),
mild (index 2) and moderate (index 3), the most differ-
ences in gene expression patterns are among severely
deformed (index 4) and extremely deformed (index 5)
embryos. Notably, all of the reference embryos exposed
to BNF + low ANF and BNF + high ANF were found to
be either severely or extremely deformed, while none of
the resistant embryos were found to be more than mod-
erately deformed in any treatment.
Discussion
Increased mortality rates among adults and embryos, de-
creased fecundity, and impairment of physiological per-
formances are likely effects of chronic exposure to
pollution among populations [37-40]. Such effects may
lead to a decrease in effective population size and gen-
etic variability [18]. However, individual responses vary,
and while some individuals are sensitive to the pollutants,
others survive and reproduce, therefore establishing resistant
AC D E
B
Figure 2 Morphology, morphology scores, and heart rate – morphology correlations of reference and resistant embryos. A) Embryo
Morphology: progression of deformities among exposed reference embryos: 1 = control embryo; 2 = 1 μg/L BNF –exposed embryo; 3 = 50 μg/L
ANF – exposed embryo; 4 = 100 μg/L ANF – exposed embryo; 5 = 1 μg /L BNF + 50 μg/L ANF – exposed embryo; 6 = 1 μg/L BNF + 100 μg/L
ANF – exposed embryo. A – atrium; BI – blood island; E – eye; CD – cranial deformity (reduced cranial width and eye distance, diminished cranial ridges);
HM – hemorrhage; M – melanin; PE – pericardial edema; TH – tube heart; V – ventricle; B) Embryo deformity assessment among reference (blue) and
resistant (red) embryos under 6 treatments. 2-way ANOVA (p < 0.010 and Bonferroni post-test (p < 0.01) revealed statistical differences in
4/6 treatments between embryo populations. Asterisks (*) represent statistically significant within-treatment differences (Bonferroni post-test, p < 0.05)
between Elizabeth River (ER - resistant) and King’s Creek (KC - reference) embryos. C) Correlation between Embryo Morphology and Heart
Rate: A) Strong correlation (R2 = 0.82) is apparent among reference embryos; B) No correlation is apparent among resistant embryos
(R2 = 0.044); C) Combined data of reference and resistant embryos shows strong correlation between progression of deformities and
decrease in heart rates (R2 = 0.78).
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ness costs so that resistance genes are rarely fixed in natural
populations [41]; counterbalancing selection pressure de-
creases the frequency of resistance genes in the absence of
inducer, such as a chemical pollutant.
Embryos are highly sensitive to pollution and exposure
to contaminated water and sediments can result in altered
development and growth and can affect survival. When ex-
posed to highly polluted sediment extracts, F. heteroclitus
embryos from reference sites show significantly higher
numbers of developmental abnormalities and do not
survive, while most of the embryos from polluted sites
are resistant and develop normally [3,4,6,7]. What
changes contribute to this resistance? Adaptation to anew environment, such as a polluted one, often involves
large modifications of the previous phenotype(s) and
changes in gene expression and regulation during critical
developmental stages may explain these phenotypic
changes. Notably, altered gene regulation can affect de-
velopment, resulting in different morphological or physio-
logical characteristics [42] that are potentially critical for
developing resistance.
Differences in survival and development between
reference and resistant embryos
Our study demonstrates important differences between
reference and resistant embryo responses during one
distinct developmental stage (late organogenesis) to a
Figure 3 Gene expression of reference and resistant embryos exposed to PAH-surrogate chemicals. A) Heat map of significant genes
reflecting all pairwise comparisons (p < 0.01) between reference and resistant embryos. Hierarchical clustering of the treatments (gene tree) is
shown on the bottom of the heat map. Red indicates relative high expression levels and green represents low expression levels. B) Expression of
105 genes differs significantly (Mixed model ANOVA, p < 0.01) due to the effect of embryo morphology among reference and resistant embryos.
Genes are clustered based on morphology scores, shown across the top of the heat map. Embryo morphology score was based on a 1–5 scale,
1 representing no deformities, 2-mild, 3-moderate, 4-severe, and 5-extreme, respectively. Subset of genes differentially expressed among severely
deformed embryos relative to other treatment groups is shown to the right of the heat map. Red indicates high expression levels and green represents
low expression levels.
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tracts. We exposed reference and resistant embryos to
surrogate model PAHs to better understand physio-
logical, morphological, and gene expression changes
underlying development in a polluted environment. By
correlating multiple phenotypes to changes in gene ex-
pression patterns, we provide additional evidence for ac-
quired resistance among embryos whose parents live at
heavily contaminated sites.
Combined treatments of β-naphthoflavone (BNF) and
α-naphthoflavone (ANF) were lethal to the reference
embryos, while the resistant embryos were largely un-
affected: all of the reference embryos failed to hatch and
died, while 70% of the resistant embryos reached the
free-swimming larval stage (Figure 1A-B). In all of the
phenotypes assessed – survival, developmental delays,
cardiac physiology (heart rate), and embryo morphology,the reference embryos were significantly more affected
than the resistant embryos: while most treatments
caused very little effect on development of resistant em-
bryos, the same exposures caused significant develop-
mental delays, impaired cardiac function, severe
morphological alterations and failure to hatch, ultimately
causing the death of reference embryos.
Development of reference embryos was significantly
delayed among reference embryos (Figure 1C) in the
high ANF exposures and both BNF-ANF co-exposures,
indicating embryotoxic effects of ANF alone [25,26] and
in synergy with BNF. On average, reference embryos
lagged almost two days (3 stages, approximately 40 hours)
behind resistant embryos given the same exposure.
Importantly, exposed resistant embryos developed within




Figure 4 Heat maps of differentially expressed genes due to population-by-treatment, treatment, and population effects among the
reference and resistant embryos exposed to PAH-surrogate chemicals (Mixed model analysis ANOVA, p < 0.01). A) Expression patterns of
73 significant genes in population-by-treatment effect; B) 52 genes are significantly different due to a treatment effect; C) 26 genes are signifi-
cantly different due to differences between reference and resistant embryo populations. Hierarchical clustering of genes based on the treatment
is shown across the top of the heat maps. Red color indicates relative high expression levels and green represents low expression levels.
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and physiology on reference and resistant embryos
Prior to hatching, reference embryos became severely
and/or extremely deformed (Figures 2A and 2B), resultingin altered physiology evident by impaired cardiac perform-
ance (Figure 1D) and failure to hatch. Although the aver-
age heart rate increased slightly among co-exposed
resistant embryos, the overall cardiac function did not
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trol embryos. We noted the most profound abnormal-
ities in cardiac morphology among reference embryos
co-exposed to BNF and ANF: the heart chambers of
these embryos failed to differentiate and ultimately re-
sembled elongated transparent tubes (“tube hearts”)
with very limited contracting ability. We observed sig-
nificant bradycardia among reference embryos co-
exposed to BNF and ANF when compared to control
embryos of both populations and resistant embryos
exposed to the same co-exposures. Other deformities
included pericardial edema, severe hemorrhaging, tail
shortening, cranio-facial shrinkage, reduced eye dis-
tance, and gross loss of pigmentation (Figure 2A). In a
few cases, the extreme deformities among reference
embryos made identifying structures difficult. In con-
trast, none of the resistant embryos co-exposed to
BNF and ANF were more than moderately deformed.
Most (95%) of the resistant embryos developed fully
differentiated heart chambers, capable of delivering
blood throughout the embryo. Abnormal morpholo-
gies among resistant embryos included slight cranio-
facial alterations, loss of pigment, mild to moderate
pericardial edema, and tail hemorrhaging. Importantly,
overall cardiac function of exposed resistant embryos
was not affected and did not significantly differ from
both reference and resistant control embryos.
We report a strong correlation (82%) between the se-
verity of morphological deformities and cardiac physi-
ology (Figure 2C-E) among reference embryos. As heart
rates significantly decrease and become inefficient in deliv-
ering blood to the tissues due to BNF-ANF co-exposures,
reference embryos become severely and extremely de-
formed. Their malformed hearts are unable to support de-
velopment and embryogenesis ceases before hatching. Such
is not the case among resistant embryos, and there is no re-
lationship between the morphology score and cardiac func-
tion: heart rates remain unaffected in all resistant embryo
treatment groups, demonstrating the ability of resist-
ant embryos to cope with the synergistic effects of
BNF-ANF co-exposure.
Gene expression differences between reference and
resistant embryos
Among the differentially expressed genes in embryos from
Elizabeth River and King’s Creek, expression of 52 genes
differs significantly due to treatment alone (Figure 4B),
and hierarchical clustering of these genes groups most
treatments of reference and resistant embryos together.
Expression of 26 genes differs significantly because of dif-
ferences between reference and resistant embryo popula-
tions (Figure 4C). Although our previous comparison of
five independent Fundulus populations using the same ar-
rays revealed 30 genes that significantly differ betweenKing’s Creek and Elizabeth River embryos at stage 31 [43],
there is no gene overlap with this data. This lack of over-
lap may reflect the fact that the current comparison exam-
ined embryos treated with PAHs while the previous
experiment examined untreated embryos collected from
parents from King’s Creek and the Elizabeth River. Some
of the changes in gene expression noted in our present
study may be simply due to changes in embryo morph-
ology due to specific chemical exposures, which do not
represent other pollutants present in the complex mix-
tures found in heavily contaminated sites. Also, the spatial
and temporal variation associated with chemical exposure
among natural populations in the wild may contribute to
changes in gene expression not observed in our study.
Expression of 72 genes differs significantly due to the
treatment-by-population interaction (Figure 4A). These
expression patterns reveal similarities between reference
embryos exposed to the higher synergy treatment and
resistant embryos exposed to the lower synergy treat-
ment. Interestingly, resistant embryos treated with the
highest co-exposure of BNF and ANF group with refer-
ence and resistant controls and reference embryos ex-
posed to low ANF, while exposure to BNF alone does
not seem to be a determining factor in the cluster
analysis.
There is a striking relationship between the morphology
score and differential expression of genes (Figure 3B). As
synergistic treatment concentrations increase among ref-
erence embryos, the severity of deformities observed
among embryos increases, causing significant overall re-
duction in embryo size, bradycardia, disproportional size
reduction of cranium including diminished distance be-
tween eyes, complete loss of cranial ridges, reduction of
eye and body pigment, hemorrhaging along the entire
shortened caudal region, cardiac edema, and complete loss
of cardiac muscle integrity characterized by the absence of
heart chambers and formation of a thin-walled, translu-
cent “tube heart”. Expression patterns of genes that correl-
ate with morphology are similar among normal to
moderately deformed embryos (1–3 on morphology
score scale), while severely deformed embryos (score
of 4) show different patterns of gene expression. Gene
expression differences become more pronounced be-
tween extremely deformed embryos when compared
to normal to moderately deformed and severely de-
formed embryos. Importantly, only reference embryos
were scored >3 in both lower and higher BNF-ANF
co-exposure treatments, providing further evidence of
PAH-resistance in the Elizabeth River (resistant) em-
bryo population.
Several genes listed in Table 1, whose expression is
correlated with observed morphological abnormalities,
are known to play an important role during organogen-
esis. Although most differences in expression are between
Table 1 Subset of embryogenesis-related genes whose expression significantly differs between reference (King’s Creek)
and resistant (Elizabeth River) Fundulus heteroclitus embryos (Mixed model ANOVA, p < 0.01) during late
organogenesis stage due to the effect of embryo morphology
Gene Fold diff. Effect Ref
Cytochrome C oxidase iso-1/iso-2 1.51 Libman-Sacks endocarditis and antiphospholipid syndrome (aPLs) [44,45]
Complement factor H-related protein 2 1.43 Libman-Sacks endocarditis and antiphospholipid syndrome (aPLs) [44,45]
Myosin light chain (ELC / RLC) 1.94/1.3 Increase in cardiomyocyte size and number, resulting in a larger ventricular
chamber volume/reduction in size and number of cardiomyocytes
[48,49]
ATP synthase subunit S 1.47 Cellular ATP synthesis; depletion of the cellular ATP pool during ischemia [46,50]
GADD45 beta 1.56 Cell-cycle control; Somitogenesis abnormalities [47]
Inositol polyphosphate multikinase (IPMK) 1.66 mRNA export, transcriptional regulation, and chromatin remodeling [51]
Phosphatidylinositol phosphate kinase 4 (PIPK) beta 2.25 Mouse embryo brain expression (cerebral ventricular and mantle zones)
during normal development; postnatal brain gray matter expression
[47]
Fumarate hydratase (fumarase) 1.77 Severe neurologic fetal brain abnormalities, poor feeding, failure to thrive;
hypotonia, severe mental retardation, unusual facial features, brain
malformation, epileptic seizures
[52,53]
The expression pattern of genes for each morphology score group is presented in Figure 3b. While gene expression appears similar among embryos scored for no
deformities (score 1), mild (score 2) and moderate (score 3), most differences in gene expression patterns are among severely deformed (score 4) and extremely
deformed (score 5) embryos. Notably, all of the reference embryos co-exposed to ANF and BNF were either severely or extremely deformed, while none of the re-
sistant embryos were found to be more than moderately deformed in any treatment.
Bozinovic et al. BMC Genomics 2013, 14:779 Page 9 of 15
http://www.biomedcentral.com/1471-2164/14/7791.4-2.3 fold, relatively small changes in transcript levels
may contribute to the morphological and physiological al-
terations observed among developing embryos. For ex-
ample, cytochrome C oxidase iso-1/iso-2 and complement
factor H-related protein 2 have 1.51 fold and 1.43 fold
higher transcript levels, respectively, among severely de-
formed reference embryos in BNF + high ANF treatment
group. Both genes are linked to cardiovascular deformities
of Libman-Sacks endocarditis and antiphospholipid syn-
drome (aPLs), marked by mitral and aortic valve lesions.
Such abnormalities can cause severe valvular insufficiency,
infective endocarditis, stroke [44] and cerebrovascular
complications [45]. We noted severe morphological alter-
ations in cardiac tissue in the form of a “tube heart” [28],
with significant bradycardia among reference embryos co-
exposed to BNF and ANF, suggesting that differences in
expression levels of these two genes among both reference
and resistant embryo populations may contribute to their
cardiac deformities. Myosin light chain isoform 1 (ELC/
RLC) and growth arrest and DNA damage-inducible pro-
tein GADD45 beta gene are upregulated (>7.3 fold and 3.3
fold, respectively) in severely deformed reference embryos
relative to all other treatment groups in both embryo pop-
ulations (Figure 3B). ELC/RLC overexpression leads to in-
crease in cardiomyocyte size and number resulting in
large ventricular chamber volume [46]. Relatively higher
expression of these genes may explain severe cardiac ab-
normalities observed in reference embryos caused by syn-
ergistic effect of BNF and ANF in BNF + high ANF
treatment group. Moreover, both knockdown and over
expression of GADD45 beta genes cause somite defects
with different consequences for marker gene expression,
suggesting that regulated expression of GADD45 betagenes in the anterior PSM is required for somite seg-
mentation [47]. Overexpression (>3.3 fold; Figure 3B)
of GADD45 in severely deformed reference embryos
may contribute to synergistic effects if BNF + high
ANF treatment and contribute to skeleto-muscular
abnormalities linked to heart abnormalities during late
embryogenesis.
Several other genes whose significant changes in expres-
sion correlate to morphology are implicated in metabol-
ism and CNS development. The ATP synthase subunit S
gene, which is >4 fold overexpressed in severely deformed
reference embryos relative to moderately-deformed refer-
ence embryos (Figure 3B) is a critical enzyme in the cell’s
energetic pathways, producing the majority of cellular
ATP and energetics of the heart which are integrally in-
volved in the causes and phenotypes of heart failure
[54,55]. Inositol polyphosphate multikinase (IPMK) plays
a critical role in nuclear functions including mRNA
export, transcriptional regulation, and chromatin re-
modeling. Ipk-2-deficient mice die around embryonic
day 9.5 with multiple morphological defects, including
abnormal folding of the neural tube [51]. IPMK dis-
plays a similar overexpression pattern as ELC/RLC
and GADD45 in severely deformed reference embryos,
likely contributing to observed severe morphological
abnormalities among reference embryos exposed to
ANF + high BNF treatment.
Notably, significantly lower expression of two genes
among reference embryos exposed to BNF + high ANF
treatment may contribute to severe morphological deform-
ities. Phosphatidylinositol phosphate kinase 4 (PIPK) beta,
which is expressed in the mouse embryo brain (cerebral
ventricular and mantle zones), plays a role in the formation
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during normal development [47]. Deficiency in fumarate
hydratase (fumarase), a gene expressed in human fetal
tissues [56] is linked to a fetal brain and severe neurologic
abnormalities, poor feeding, failure to thrive, hypotonia,
encephalopathy [52], severe mental retardation, unusual
facial features, brain malformation, and epileptic seizures
[53]. We noted significant reduction in head size and
complete loss of cranial ridges in severely deformed
reference embryos.
Due to severe morphological abnormalities oberved
among reference embryos, it was often difficult to accur-
ately stage the embryos, which likely confounded some
of our gene expression analyses. Significant changes in
gene expression that corelate with morphology are simi-
lar among normal to moderately deformed embryos,
while severely deformed embryos show different patterns
of gene expression (Figure 3B). Moreover, the gene ex-
pression differences become more pronounced between
extremely deformed embryos, when compared to both
normal to moderately deformed and severely deformed
embryos. Importantly, synergistic effects of BNF and
ANF were only evident among severely and extremely
deformed reference embryos, providing further evidence
of PAH-resistance in the Elizabeth River (resistant) em-
bryo population.
Few genes contribute to large phenotypic changes
between embryo populations
Despite the striking differences in embryo morphology
between reference and resistant embryos, a relatively low
percentage of genes (2.24% of 6,764) showed statistically
significant differences in transcript levels (Figure 3A). This
percentage is less than the percentage of genes signifi-
cantly differentially expressed between PCB treated em-
bryos from another resistant Fundulus population and a
nearby reference site. At 15 days post-fertilization, 2.4% of
genes differ with an FDR p-value of <0.01 between em-
bryos from New Bedford Harbor, which are resistant to
PCBs, and embryos from a reference population treated
with PCBs [57]. Previous results comparing untreated em-
bryos from parents collected from polluted resistant and
reference populations also found a surprisingly small
number of significantly differently expressed genes (using
the same microarray platform, 0.8% of the genes differed
significantly between embryos collected from parents
from the Elizabeth River population and nearby reference
populations [43]). One possible explanation for this find-
ing was that differences would only manifest in the correct
environment (e.g., gene by environment interactions).
Given the data presented here, this explanation appears
not to be true (at least for the combined treatment of BNF
and ANF). Considering the large variation in gene expres-
sion reported within and among multiple reference andresistant adult F. heteroclitus populations [27,28,58-60],
this low percentage of genes whose expression signifi-
cantly differs between both treated and untreated refer-
ence and resistant embryo populations is unexpected.
This small percentage of significantly differentially
expressed genes may be due to several factors. Relatively
small changes in gene expression not detected by our
analysis may be biologically important during late or-
ganogenesis. We did not test all of the genes expressed
during development, so some of the important gene ex-
pression differences were likely missed. Also, some of
the significant gene expression differences may be
masked by large changes in gene expression that occur
between stages during normal Fundulus development
[61]. Our analysis was performed on whole embryos,
thus potentially masking some tissue-specific gene ex-
pression differences. Critical differences in gene expres-
sion may occur at earlier or later developmental stages
than the one we examined (stage 31, late organogenesis).
However, a recent transcriptome comparison of PCB-
exposed reference and resistant Fundulus embryos at
two time-points during embryogenesis [5 and 10 days
post fertilization (dpf), approximately stage 28–29, and
35, respectively] and one larval stage (15 dpf, approxi-
mately stage 39–40) revealed a stage-specific response
and cumulative pollutant effect reflected by the increase
of significantly expressed genes at later stages [57]. Ar-
guably, more robust tissue-specific changes in gene ex-
pression occur during early development, particularly
during early CNS (stages 16–19) and cardiovascular or-
ganogenesis (stages 16–25).
Finally, increasing a relatively small biological sample size
per treatment (N = 4) and statistical power in our micro-
array analysis could have revealed more statistically signifi-
cant genes. Previous tissue-specific studies on Fundulus
adults using only one more individual (five versus four)
from these same populations have reported up to 40% of
genes that differ due to treatment (population) [27,58].
However, our recently published study comparing eight
resistant and twelve reference, untreated embryos during
late organogenesis using the same microarray platform re-
vealed less than 1% of significant differently expressed
genes [43]. Although we identified significant changes
in gene expression and correlated them with multiple
phenotypes, other factors not considered in our study,
such as post-translational modifications and changes
in protein expression and enzyme activity are likely
contributors to observed differences between resistant
and reference embryo populations.
Conclusions
Our study demonstrates important contrasts in responses
between reference and resistant natural embryo popula-
tions to synergistic effects of surrogate model PAHs that
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PAH effects during fish embryo development. While the
reference embryos become severely deformed and none
survive ANF/BNF co-exposures, the absence of moderate
and severe deformities, lack of significant changes in heart
rates and developmental delays, and >70% survival among
resistant embryos co-exposed with BNF and ANF relative
to reference and resistant control embryos clearly demon-
strates the resistant embryos’ ability to adapt and survive.
By analyzing multiple phenotypes and linking them to
gene expression patterns of reference and resistant em-
bryos, we provide additional evidence for acquired re-
sistance among embryos whose parents live at heavily
contaminated sites: while most treatments caused very
little effect on development of resistant embryos, synergis-
tic effects of a PAH-type representative AHR agonist and
CYP1A inducer caused developmental delays, impaired
cardiac function, morphological alterations, and mortality
of reference embryos. These phenotypes mirror embryo re-
sponses observed during exposure to complex mixtures of
pollutants found in Elizabeth River sediment extracts, but
in contrast to exposure to sediment extracts that signifi-
cantly altered expression of many genes (20% of 6,551
genes, unpublished data), we found a surprisingly small
percentage of significantly differentially expressed genes
(2.24% of 6,764 genes) upon treatment with a mixture of
two model PAHs, α-napthoflavone and β-napthoflavone.
These results suggest that relatively few genes contribute
to the large phenotypic changes seen among reference and
resistant populations upon exposure to PAH pollutants.
Methods
Fish care
Adult Fundulus were collected from both a reference
site at King’s Creek, near the mouth of the York River in
Gloucester County, Virginia (37°17′52.4″N, 76°25′31.4″W)
and from a contaminated site on the Elizabeth River in
Portsmouth, Virginia (36°48′27.48″N, 76°17′35.77″W).
Adult fish were depurated for 12 months in a recirculating
system containing artificial seawater (ASW 25 ppt) pre-
pared from Instant Ocean® (Mentor, OH). Fish were kept at
23-25°C on a photoperiod of 14:10 L:D and fed a
daily diet of Tetramin® Tropical Fish Food (Tetra Systems,
Blacksburg VA, USA) and newly hatched brine shrimp
(Artemia, Brine Shrimp Direct, Ogden, UT). Killifish
embryos were obtained from in vitro fertilization of pooled
oocytes mixed with pooled milt from multiple males.
Embryos were examined 24 hours post fertilization
(hpf) for viability and placed individually into 20 mL glass
scintillation vials with 10 mL of treatment solution.
Chemicals and exposure
Dimethyl sulfoxide (DMSO), ANF, BNF and ethoxyre-
sorufin were purchased from Sigma-Aldrich (St. Louis,MO). King’s Creek (reference) embryos and Elizabeth
River (sensitive embryos) were exposed to the following
treatments:
Treatment 1: DMSO / vehicle (Control)
Treatment 2: 1 ug/L BNF (BNF)
Treatment 3: 50 ug/L ANF (low ANF)
Treatment 4: 100 ug/L ANF (high ANF)
Treatment 5: 1 ug/L BNF + 50 ug/L ANF
(BNF + low ANF)
Treatment 6: 1 ug/L BNF + 100 ug/L ANF
(BNF + high ANF).
Individual embryos of parents from both populations
were exposed to the treatment solution or to the DMSO
vehicle control from 24 to 120 hpf (n = 20). In all of the
treatment groups, DMSO concentration was maintained
at less than 0.03%. At 120 hpf, embryos were removed
from the dosing solution and placed into vials containing
clean ASW.
Embryo survival, developmental delays, and heart rate
Fertilization success and embryo progress were moni-
tored daily by examining representative stages during
pre-determined time periods [61,62] using a dissecting
stereo microscope (Nikon SME1500, Japan). Stage pro-
gression, developmental delays, normal versus abnormal de-
velopment, and mortality also were recorded. Unfertilized
eggs, malformed and/or dead embryos were removed from
the population, and times and stages of arrest and abnormal
development were recorded accordingly. Survival rates were
measured within each treatment in both populations.
Embryos that successfully reached stage 31 were used
for heart rate and gene expression analysis. Ten em-
bryos from each treatment group were assessed for
hatching success and survival to complete embryogen-
esis, marked with the total yolk consumption by the
free-swimming Fundulus [61,62].
To determine developmental delays, ten embryos from
each population were monitored in individual 20 ml
scintillation vials. Identification of each stage was deter-
mined using a dissecting stereo microscope at 70-80X
magnification. At approximately 144–150 hpf, when the
embryos were expected to reach stage 31 [61,62], multiple
images of developing embryos were captured with the
Micropublisher 5.0 RTV Camera (QImaging). These
images were catalogued, stored, and analyzed using
QCaputre Pro imaging software. Each embryo was scored
based on multiple morphological characteristics and
assigned the appropriate developmental stage.
The same embryos used to determine developmental
delays were used to determine heart rates during early
organogenesis (stage 31). A beating heart is formed,
with both chambers completely differentiated and in
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ately measured from that stage on. Embryo vials were
labeled to assure that the heart rate was measured
from the same embryo at both stages. Individual em-
bryos were placed on a depression slide under the dis-
secting stereo microscope for 1 minute prior to taking
heart rate measurements so that the stressed embryo
could re-establish resting heart beat (most Fundulus em-
bryos temporarily arrest their heart beat due to a sudden
change of environment, such as transfer from the petri
dish to a well-lit slide surface). The heart rate of each em-
bryo was measured by counting the number of heartbeats
for 30 seconds (preliminary results showed no change in
the average heart beat when counts were taken at either
30 second or 1 minute intervals).
Embryo morphology
At 168 hours-post-fertilization (hpf ), ten embryos from
each treatment were randomly selected and subjectively
scored treatment-blind twice independently (N = 2) for
morphological abnormalities using light microscopy.
Embryos were scored for severity of heart deformities
(tube heart), pericardial edema, hemorrhaging, cranio-
facial alterations, tail shortening, and pigment loss. Em-
bryo score was based on a 1–5 scale, 1 representing no
deformities, 2-mild, 3-moderate, 4-severe, and 5-extreme,
respectively. Non-deformed embryos appeared wrapped
approximately 2/3 around the full circumference of the
remaining yolk, and with clearly distinguishable cranial
ridges, well-defined dark-pigmented eyes with visible ret-
inas, dark and scattered body pigment, clearly distinct
atrial and ventricular cardiac regions, absence of hemor-
rhaging, and the caudal region approximately 1/3 of the
body length beginning at the bilobed urinary bladder [61].
The most severely affected embryos were characterized by
overall smaller size, disproportional size reduction of
cranium including diminished distance between eyes,
complete loss of cranial ridges, reduction of eye pig-
mentation, near-complete aggregation and overall re-
duction of body pigmentation, hemorrhaging along the
entire shortened caudal region, and complete loss of
cardiac muscle integrity characterized by the absence
of heart chambers and formation of a thin-walled,
translucent “tube heart”.
Results for each treatment were represented as an
average of the individual scores.
While all phenotypes were considered in determining
the final score, the heart deformities were found to be
the most reference and reliable endpoint used in de-
formity assessment.
These experiments were performed according to ap-
proved protocols (Institutional Animal Care and Use
Committees, North Carolina State University and Duke
University).Survival, heart rate, developmental delays, and morphology
statistical analysis
Differences in the survival, heart rate, developmental de-
lays, and morphology, among two embryo populations
and six treatments were analyzed with Prism Statistical
Software. Data were normally distributed and were ana-
lyzed using one-way Analysis of Variance (1-way ANOVA,
p < 0.05); pairwise t-test was used to test the differences
of means between treatment groups, while Dunnett’s
one-tailed t-test was used to evaluate differences between
“reference” embryos and “resistant” embryos, respectively.
Microarrays
Amplified cDNA sequences for 7,000 genes from F.
heteroclitus cDNA libraries were spotted onto epoxide
slides (Corning) using an inkjet printer (Aj100, ArrayJet,
Scotland). Libraries were made from all 40 stages of
Fundulus development, immediately post-hatch whole
larvae, and adult tissues. Each slide contained four spatially
separated arrays of ~7,000 spots (genes) including controls.
Sequence information, annotation and gene ontology are
available for Fundulus on the FunnyBase website http://
www.ccs.miami.edu/cgi-bin/Fundulus/Fundulus_home.cgi.
Embryo RNA isolation, amplification, and labeling
Four individual embryos from each treatment at devel-
opmental stage 31 [62] were used for RNA isolation, la-
beling, and microarray hybridization. Embryo RNA was
extracted using a TRIzol buffer (Invitrogen, Carlsbad,
CA, USA) followed by purification using the Qiagen
RNeasy Mini Kit (Qiagen Inc., Valencia, CA, USA).
Purified RNA was quantified with a spectrophotom-
eter, and RNA quality was assessed by gel electrophor-
esis. RNA for hybridization was prepared by one round
of amplification (aRNA) using Ambion’s Amino Allyl
MessageAmp aRNA Kit to form copy template RNA by
T7 amplification. Amino-allyl UTP was incorporated
into targets during T7 transcription, and resulting
amino-allyl aRNA was coupled to Cy3 and Cy5 dyes
(GE Healthcare, Piscataway, NJ, USA).
Labeled aRNA samples (2 pmol dye/μl) were hybrid-
ized to slides in 10 μl of hybridization buffer [50% form-
amide buffer, 5x SSPE, 1% sodium dodecyl sulfate,
0.2 mg/ml bovine serum albumin, 1 mg/ml denatured
salmon sperm DNA (Sigma), and 1 mg/ml RNase free
poly(A) RNA (Sigma)] for 44 hours at 42°C. Slides
were prepared for hybridization by blocking in 5% eth-
anolamine, 100 mM Tris pH 7.8, and 0.1% SDS added
just before use for 30 minutes at room temperature,
washed for one hour in 4x SSC, 0.1% SDS at 50°C, and
then boiled for 2 minutes in distilled water to denature
the cDNAs. Resulting 16 bit Tiff Images were quanti-
fied using ImaGene® (Biodiscovery, Inc.) spotfinding
software. Controls and any gene that did not have at
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average signal from all herring sperm control spots
(non-specific hybridization signal) plus one standard
deviation were removed prior to statistical analysis. In
total, 6,754 genes were analyzed.
Experimental design for microarrays
A loop design (Figure 5) was used for the microarray hy-
bridizations where each sample is hybridized to 2 arrays
using both Cy3 and Cy5 labeled fluorophores [63]. The
loop consisted of Cy3 and Cy5 labeled embryo aRNAs
from 4 biological samples and six different treatments
(T1-T6: control, 1 μg/L BNF, 50 μg/L ANF, 100 μg/L
ANF, 1 μg/L BNF + 50 μg/L ANF, 1 μg/L BNF + 100 μg/L
ANF). In total, 48 biological samples were hybridized to
24 microarrays. Each array had different combinations
of biological samples, so that the most direct compari-
sons (i.e., 50 μg/L ANF resistant embryo and 50 μg/L
reference embryo) are hybridized to the same array. The
loop formed was T1S → T1R → T2S → T2R → T3S →
T3R → T4S → T4R → T5S → T5R → T6S → T6R →Figure 5 BNF-ANF treatment exposures and microarray loop design:
labeled fluorophores. The loop consisted of Cy3 and Cy5 labeled embryo
control, 1 μg/L BNF, 50 μg/L ANF, 100 μg/L ANF, 1 μg/L BNF + 50 μg/L AN
and CYP450IA genes are shown with up and down green/red arrows abov
microarrays. Each array had different combinations of biological samples, so
and 50 μg/L reference embryo) are hybridized to the same array. The loop
T5S→ T5R→ T6S→ T6R→ T1S→ T2S→ T3S→ T4S→ T5S→ T6S→ T1S→
a separate hybridization (array) with the biological sample at the base o
the arrow labeled with Cy5. T1-6 is treatment, and S and R represent ref
loop design shows treatments as numbers, and arrows as separate hybrT1S → T2S → T3S → T4S → T5S → T6S → T1S →
T1R → T2R → T3R → T4R → T5R → T6R, where each
arrow represents a separate hybridization (array) with the
biological sample at the base of the arrow labeled with Cy3
and the biological pool at the head of the arrow labeled
with Cy5. T1-6 is treatment, and S and R represent refer-
ence and resistant embryos.
Microarrays statistical analysis
Log2 measures of gene expression were normalized
using a linear mixed model in SAS (JMP v6.0.0 with a
microarray platform beta-version in SAS v9.1.3) to re-
move the effects of dye (fixed effect) and array (random
effect) following a joint regional and spatial Lowess
transformation in MAANOVA Version 0.98.8 for R to
account for both intensity and spatial bias [64].
The model was of the form yij = μ +Ai + Dj + (AxD)ij + ɛij,
where, yij is the signal from the i
th array with dye j, μ is the
sample mean, Ai and Dj are the overall variation in arrays
and dyes (Cy3 and Cy5), (AxD)ij is the array x dye inter-
action and ɛij is the stochastic error [65,66].each sample is hybridized to 2 arrays using both Cy3 and Cy5
aRNAs from 4 biological samples and six different treatments (T1-T6:
F, 1 μg/L BNF + 100 μg/L ANF). Anticipated treatment effects on AHR
e the treatments. 48 biological samples were hybridized to 24
that the most direct comparisons (i.e., 50 μg/L ANF resistant embryo
formed was T1S→ T1R→ T2S→ T2R→ T3S→ T3R→ T4S→ T4R→
T1R→ T2R→ T3R→ T4R→ T5R→ T6R, where each arrow represents
f the arrow labeled with Cy3 and the biological pool at the head of
erence and resistant embryos, respectively. A shorter example of the
idization (array).
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by-gene analyses of treatment effect during a particular
developmental stage, using treatment, population x treat-
ment, and dye as fixed effects, and array and spot nested
in array as random effects. The model was rijkng = μ +Ai +
Dj + Tk + Pn + (TxP)nk + ɛijkn where Tk is the k
th treatment
(treatments 1–6, above), Pn is the n
th population (refer-
ence or resistant), and (TxP)nk is the treatment by
population interaction. We also used residuals for a
gene-by-gene analysis of morphology: rijk = μ +Ai + Dj +
Mk + ɛijk where Mk is the k
th morphology (morphology
score 1 – 5 where 1 is normal and 5 is extremely
deformed).
For all mixed model analyses, we used a nominal
p-value cut-off for significant genes of p < 0.01. Using
this p-value reveals more genes that may be differen-
tially expressed but risks identifying genes that may be
false positives.
Hierarchical clustering used JmpGenomics, Cluster 3.0
for Mac OS X, and Java TreeView version 1.0.8 [67].
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